Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Sep 17, 2022 3:00pm
72 Views
Post# 34969159

RE:RE:RE:Grahamx

RE:RE:RE:Grahamx
G1945V wrote: Graham, you said: "Norm, the post was and is directed entirely to you.
I have made no comments regarding the company, only about you as a promoter that is misrepresenting."


If that is what you meant why did you post the following link?

https://www.osc.ca/sites/default/files/pdfs/irps/csa_20181129_51-356_problematic-promotional-activities-issuers.pdf

The linked article as I understand it deals strictly with the issuer of the stock, misleading the investing public.


Yes this is directed to Norm, as he is the one posting this-as I stated in the post.

My reading of this OSC statement  is the qualifier, ‘or on behalf of,”(1)would include stock promoters/pumpers that own the stock.
So its not directed just to the issuer, as I read and understand it.

 

I dont read it that they are employees, but if you own shares, you are a co-owner, thus promotion of the company, that could inflate the price, would benefit you…hence “on behalf of” 

 

(1)

https://www.osc.ca/sites/default/files/pdfs/irps/csa_20181129_51-356_problematic-promotional-activities-issuers.pdf

 

There is also very direct reference to promoters on stock chat boards that are relevant:

 

 

"Pump and dump" schemes have two parts.  In the first, promoters try to boost the price of a stock with false or misleading statements about the company.  Once the stock price has been pumped up, fraudsters move on to the second part, where they seek to profit by selling their own holdings of the stock, dumping shares into the market.

These schemes often occur on the Internet where it is common to see messages urging readers to buy a stock quickly.  Often, the promoters will claim to have "inside" information about a development that will be positive for the stock.  After these fraudsters dump their shares and stop hyping the stock, the price typically falls, and investors lose their money.

Pump and dump schemes typically involve little-known microcap companies. For more information”

 

https://www.sec.gov/reportspubs/investor-publications/investorpubscyberfraudhtm.html

 

So yes, stating something that isn’t true to profit from it, to pump up the stock -is fraud.

 

In this case it is stated that : “Wars over buddy, you lost. Being recommend by NICE means VPT is now the standard of care for cardiac patients in the UK replacing expensive MRI imaging.”

 

This isn’t true, as I understand it.

So I dont think regulations around posting untrue statements are only for issuers, but a stock promoter that owns the stock (part of the company) But I am not a securities lawyer.

..and he still hasn't retracted his statement.




jmo
G1945V


<< Previous
Bullboard Posts
Next >>